These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 27692115)
81. Physical Activity and Sedentary Behavior in Cardiac Rehabilitation: Does Body Mass Index Matter? den Uijl I; Ter Hoeve N; Sunamura M; Lenzen MJ; Braakhuis HEM; Stam HJ; Boersma E; van den Berg-Emons RJG Phys Ther; 2021 Sep; 101(9):. PubMed ID: 34089325 [TBL] [Abstract][Full Text] [Related]
82. The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project. Li W; Wang D; Wang X; Gong Y; Cao S; Yin X; Zhuang X; Shi W; Wang Z; Lu Z BMC Public Health; 2019 Feb; 19(1):192. PubMed ID: 30764803 [TBL] [Abstract][Full Text] [Related]
84. Metabolic impairments in patients with myotonic dystrophy type 2. Vujnic M; Peric S; Calic Z; Benovic N; Nisic T; Pesovic J; Savic-Pavicevic D; Rakocevic-Stojanovic V Acta Myol; 2018 Dec; 37(4):252-256. PubMed ID: 30944903 [TBL] [Abstract][Full Text] [Related]
85. Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy. Wille E; Scholze J; Alegria E; Ferri C; Langham S; Stevens W; Jeffries D; Uhl-Hochgraeber K Eur J Health Econ; 2011 Jun; 12(3):205-18. PubMed ID: 20405160 [TBL] [Abstract][Full Text] [Related]
86. Bariatric Surgery as a Long-Term Treatment for Type 2 Diabetes/Metabolic Syndrome. Hanipah ZN; Schauer PR Annu Rev Med; 2020 Jan; 71():1-15. PubMed ID: 31986081 [TBL] [Abstract][Full Text] [Related]
87. Secular Trend of Metabolic Syndrome and Its Components in a Cohort of Iranian Adults from 2001 to 2013. Khosravi-Boroujeni H; Sarrafzadegan N; Sadeghi M; Roohafza H; Talaei M; Ng SK; Phung H; Pourmogaddas A; Ahmed F Metab Syndr Relat Disord; 2017 Apr; 15(3):137-144. PubMed ID: 28135122 [TBL] [Abstract][Full Text] [Related]
88. Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome. Arca M Drugs; 2007; 67 Suppl 1():43-54. PubMed ID: 17910520 [TBL] [Abstract][Full Text] [Related]
89. Metabolic syndrome: cardiovascular risk assessment and management. Wong ND Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567 [TBL] [Abstract][Full Text] [Related]
90. Gender-specific care of the patient with diabetes: review and recommendations. Legato MJ; Gelzer A; Goland R; Ebner SA; Rajan S; Villagra V; Kosowski M; Gend Med; 2006 Jun; 3(2):131-58. PubMed ID: 16860272 [TBL] [Abstract][Full Text] [Related]
91. Putting the Diabetes Prevention Program into practice: a program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus. McBride PE; Einerson JA; Grant H; Sargent C; Underbakke G; Vitcenda M; Zeller L; Stein JH J Nutr Health Aging; 2008 Dec; 12(10):745S-749S. PubMed ID: 19043651 [TBL] [Abstract][Full Text] [Related]
92. Differences Between Morbid Obesity With Metabolic Syndrome and Overweight Turkish Adult Participants in Multiple Atherosclerotic Cardiovascular Disease Risk Factors. Bostan C; Kaya A; Yigit Z Angiology; 2021 Feb; 72(2):131-137. PubMed ID: 33143460 [TBL] [Abstract][Full Text] [Related]
93. Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk. Said S; Mukherjee D; Whayne TF Curr Vasc Pharmacol; 2016; 14(5):415-425. PubMed ID: 27456105 [TBL] [Abstract][Full Text] [Related]
94. Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome. Padwal RS; Sharma AM Can J Cardiol; 2010; 26 Suppl C(Suppl C):18C-20C. PubMed ID: 20847987 [TBL] [Abstract][Full Text] [Related]
95. Novel Therapeutics for Type 2 Diabetes, Obesity, and Heart Failure: A REVIEW AND PRACTICAL RECOMMENDATIONS FOR CARDIAC REHABILITATION. Khadanga S; Barrett K; Sheahan KH; Savage PD J Cardiopulm Rehabil Prev; 2023 Jan; 43(1):1-7. PubMed ID: 36576423 [TBL] [Abstract][Full Text] [Related]
96. Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts. Shi M; Han S; Klier K; Fobo G; Montrone C; Yu S; Harada M; Henning AK; Friedrich N; Bahls M; Dörr M; Nauck M; Völzke H; Homuth G; Grabe HJ; Prehn C; Adamski J; Suhre K; Rathmann W; Ruepp A; Hertel J; Peters A; Wang-Sattler R Cardiovasc Diabetol; 2023 Jun; 22(1):141. PubMed ID: 37328862 [TBL] [Abstract][Full Text] [Related]
97. Dietary patterns, inflammation and the metabolic syndrome. Ahluwalia N; Andreeva VA; Kesse-Guyot E; Hercberg S Diabetes Metab; 2013 Apr; 39(2):99-110. PubMed ID: 23062863 [TBL] [Abstract][Full Text] [Related]
98. Prevention of cardiovascular risk factors: moving upstream. Smith ER Can J Cardiol; 2010; 26 Suppl C(Suppl C):7C. PubMed ID: 20847984 [No Abstract] [Full Text] [Related]
99. Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome. O'Neill BJ Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):301-307. PubMed ID: 32773574 [TBL] [Abstract][Full Text] [Related]
100. Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores. Gurka MJ; Filipp SL; Pearson TA; DeBoer MD J Am Heart Assoc; 2018 Aug; 7(16):e009754. PubMed ID: 30369320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]